Clinical variants of venous thromboembolism in patients with hereditary thrombophilia

Burleva E.P.

Kafedra obshcheĭ khirurgii GOU VPO "Ural'skaia gosudarstvennaia meditsinskaia akademiia", Ekaterinburg

Novikova Ia.V.

Institut khimicheskoĭ biologii i fundamental'noĭ meditsiny SO RAN, Novosibirsk

Sevost'ianova K.S.

Institut khimicheskoĭ biologii i fundamental'noĭ meditsiny SO RAN, Novosibirsk

Voronina E.N.

Institut khimicheskoĭ biologii i fundamental'noĭ meditsiny SO RAN, Novosibirsk

Belova A.D.

MU Tsentral'naia gorodskaia bol'nitsa #2, Ekaterinburg

Clinical variants of venous thromboembolism in patients with hereditary thrombophilia

Authors:

Burleva E.P., Novikova Ia.V., Sevost'ianova K.S., Voronina E.N., Belova A.D.

More about the authors

Journal: Journal of Venous Disorders. 2011;5(3): 58‑63

Downloaded: 16

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Burleva EP, Novikova IaV, Sevost'ianova KS, Voronina EN, Belova AD. Clinical variants of venous thromboembolism in patients with hereditary thrombophilia. Journal of Venous Disorders. 2011;5(3):58‑63. (In Russ.)

Подписка 2025-2 (Journal of Venous Disorders)

Close metadata

Recommended articles:

Efficacy and Safety of Different Anticoagulation Regimens for Deep Vein Thrombosis in Real Clinical Practice. Journal of Venous Disorders. 2024;(2):89-99

Risk Factors of Bleedings in Patients with COVID-19 Receiving Anticoagulants for Venous Thromboembolism Prevention. Journal of Venous Disorders. 2024;(3):222-231

Positive Predictive Value of the Wells Score in Diagnosis of Deep Vein Thrombosis: Results of Bayesian Analysis. Journal of Venous Disorders. 2024;(4):274-282

Asplenia — a new cause of thrombosis in pregnant women?. Russian Bulletin of Obstetrician-Gynecologist. 2025;(1):71-76

Three variants of venous thromboembolism in patients with hereditary thrombophilia are considered. The authors maintain that specific combinations of genetic prothrombotic polymorphisms as well as their combination with a variety of acquired risk factors play the key role in the formation of thrombophilic status in individual patients. It is concluded the comprehensive molecular-genetic analysis provides a reliable basis for making clinical decisions, in the first place for the determination of the character and duration of therapeutic, prophylactic, and rehabilitative programs.

Keywords:

venous thromboembolism

hereditary thrombophilia

genetic polymorphisms

Authors:

Burleva E.P.

Kafedra obshcheĭ khirurgii GOU VPO "Ural'skaia gosudarstvennaia meditsinskaia akademiia", Ekaterinburg

Novikova Ia.V.

Institut khimicheskoĭ biologii i fundamental'noĭ meditsiny SO RAN, Novosibirsk

Sevost'ianova K.S.

Institut khimicheskoĭ biologii i fundamental'noĭ meditsiny SO RAN, Novosibirsk

Voronina E.N.

Institut khimicheskoĭ biologii i fundamental'noĭ meditsiny SO RAN, Novosibirsk

Belova A.D.

MU Tsentral'naia gorodskaia bol'nitsa #2, Ekaterinburg

List of references:

Makatsariya A.D., Bitsadze V.O. Trombofilii i protivotromboticheskaya terapiya v akusherskoi praktike. M: Triada-Kh 2003;904.
Barkagan Z.S., Tsyvkina L.P., Kostyuchenko G.I., Momot A.P. Klassifikatsiya, molekulyarnye mekhanizmy i novye metody diagnostiki trombofilii. Byul SO RAMN 2002;6:181-185.
Rekomendatsii po diagnostike i lecheniyu tromboembolii legochnoi arterii. Otchet rabochei gruppy Evropeiskogo obshchestva kardiologov. Klin farmakol i ter 2001;10:1:84-90.
Handbook of venous disorders. 3d ed. Guidelines of the American Venous Forum. Ed. P. Gloviczki. Hodder Arnold 2009;113.
Martinelli I., Cattaneo M., Panzeri D., Manucci P.M. Low prevalence of factor V:Q506 with 41 patients with isolated pulmonary embolism. Thromb Haemost 1997;77:440-443.
Endler G., Mannhalter C. Polymorphisms in coagulation factor genes and there impact on arterial and venous thrombosis. Clin Chim Acta 2003;330:31-55.
Yilmazer M., Kuttay G., Sonmezer M., Akar N. Factor V Leiden and protrombin 20210G-A mutations in controls and in patients with thromboembolic events during pregnancy or the puerperium. Arch Gynecol Obstet 2003;268:304-308.
Avdonin P.V., Kirienko A.I., Kozhevnikova L.M. i dr. Korrelyatsiya nalichiya mutatsii S677T v gene metilentetragidrofolatreduktazy u bol'nykh tsentral'nogo regiona Rossii s venoznymi trombozami i povyshennyi risk tromboembolii legochnoi arterii. Ter arkh 2006;6:70-76.
Shevela A.I., Sevost'yanova K.S., Novikova Ya.V., Voronina E.N. Osnovnye tendentsii raspredeleniya protromboticheskikh polimorfizmov genov u patsientov s flebotrombozami Novosibirska. Ekologiya cheloveka 2010;7:36-40.
Bokeriya L.A., Bokeriya O.L., Lyadov K.V., Lemaeva I.V. Geneticheskie faktory riska trombofilicheskikh sostoyanii. Klin fiziol krovoobr 2008;2:69-72.
Polyanko N.I., Zairat'yants O.V., Ipatov P.V. i dr. Kliniko-morfologicheskaya kharakteristika i faktory prognoza tromboembolii legochnoi arterii. Arkh pat 2007;69:1:32-35.
Shostak N.A., Kirienko A.I., Leont'ev S.G. i dr. Antifosfolipidnyi sindrom v strukture gematogennoi trombofilii u patsientov s venoznymi trombozami molodogo i srednego vozrasta. Ter arkh 2005;5:47-51.
Leont'ev S.G., Zolotukhin I.A., Seliverstov E.I. i dr. Ambulatornoe lechenie trombozov glubokikh ven nizhnikh konechnostei. Flebologiya 2009;4:41-44.
Blattler W., Gerlach H.E. Implementation of Outpatient Treatment of Deep-vein Thrombosis in Private Practices in Germany. Eur J Vasc Endovasc Surg 2005;30:3:319-324.
Parisi R., Visona A., Camporese G. et al. Isolated distal deep vein thrombosis: efficacy and safety of a protocol of treatment. Treatment of Isolated Calf Thrombosis (TICT) Study. Int Angiol 2009;28:1:68-72.
Partsch H. Ambulation and compression after deep vein thrombosis: dispelling myths. Vasc Surg 2005;18:3:148-152.

Close metadata